Profiel
Laura Saward formerly worked at Cangene Corp., as Chief Scientific Officer from 2012 to 2014, Emergent BioSolutions, Inc., as SVP & Antibody Therapeutics Business Unit from 2017 to 2021, and Manitoba Health Research Council, as Member.
Dr. Saward received her undergraduate degree from the University of Guelph and doctorate degree from the University of Manitoba.
Eerdere bekende functies van Laura Saward
| Bedrijven | Functie | Einde |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01-10-2021 |
| CANGENE CORPORATION | Chief Tech/Sci/R&D Officer | 01-04-2014 |
| Manitoba Health Research Council | Corporate Officer/Principal | - |
Opleiding van Laura Saward
| University of Guelph | Undergraduate Degree |
| University of Manitoba | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Cangene Corp.
 Cangene Corp. Pharmaceuticals: MajorHealth Technology Cangene Corp. developed, manufactured and sold biopharmaceutical drugs. The company was founded on February 22, 1984 and was headquartered in Winnipeg, Canada. | Health Technology |
| Manitoba Health Research Council |
